Related references
Note: Only part of the references are listed.Improving the public health: The US recommendation for universal influenza immunization
Gregory A. Poland et al.
VACCINE (2010)
Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older
Ann R. Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study
Robert Arnou et al.
VACCINE (2009)
Biology of immune responses to vaccines in elderly persons
Birgit Weinberger et al.
CLINICAL INFECTIOUS DISEASES (2008)
Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice
Jean-Francois Nicolas et al.
EXPERT REVIEW OF VACCINES (2008)
Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: A randomized controlled trial
David Holland et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?
Paul Henri Lambert et al.
VACCINE (2008)
Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system
Philippe E. Laurent et al.
VACCINE (2007)
MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection
Derek T. O'Hagan
EXPERT REVIEW OF VACCINES (2007)
The perfect mix: recent progress in adjuvant research
Bruno Guy
NATURE REVIEWS MICROBIOLOGY (2007)
Antibody response to influenza vaccination in the elderly: A quantitative review
K Goodwin et al.
VACCINE (2006)
Seroprotection rate, mean fold increase, seroconversion rate:: which parameter adequately expresses seroresponse to influenza vaccination?
WEP Beyer et al.
VIRUS RESEARCH (2004)
Serum antibody responses after intradermal vaccination against influenza
RB Belshe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Dose sparing with intradermal injection of influenza vaccine
RT Kenney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines
KL Nichol
VACCINE (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
A Podda
VACCINE (2001)
Share Paper
